Decibel Therapeutics Inc. (DBTX) NASDAQ
$4.91 (0.04) (-0.81%)
Market Cap: -
As of 09/22/23 04:00 PM EDT. Market closed.
Decibel Therapeutics Inc. (DBTX)
NASDAQ
$4.91
(0.04) (-0.81%)
Market Cap: -
As of 09/22/23 04:00 PM EDT. Market closed.
Add to Portfolio
decibel therapeutics is a hearing company focused on discovering and developing new medicines to protect, repair and restore hearing. hearing loss is the most prevalent form of sensory impairment. it is estimated that 50 million people in the u.s., and 360 million people worldwide, suffer from some type of hearing loss. hearing disorders affect people of all ages and can have a profound impact on ... read more
COMPANY PROFILE
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
PRICE CHART FOR DECIBEL THERAPEUTICS INC
From:
To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
$5.04
Previous Close
$4.95
Days Range
$4.90 - $5.11
52 week range
- - -
Volume
0
Avg. Volume (30 days)
0
Market Cap
-
Dividend Yield
-
P/E
-
Shares Outstanding
25,126,935
Open
$5.04
Previous Close
$4.95
Days Range
$4.90 - $5.11
52 week range
- - -
Volume
0
Avg. Volume (30 days)
0
Market Cap
-
Dividend Yield
-
P/E
-
Shares Outstanding
25,126,935
FINANCIAL STATEMENTS FOR DECIBEL THERAPEUTICS INC
LOADING...
Open in: 
Open in:
INSIDER TRANSACTIONS FOR DECIBEL THERAPEUTICS INC
| Owner | Relationship | Date | Transaction | Cost | # Shares | Value($) | Total Shares | Form 4 |
| Trask Anna | See Remarks | Dec 02, 2021 | Sale | $6.37 | 5,291 | 33,688 | 2,620 | Dec 06, 2021, 04:20 PM |
| Trask Anna | See Remarks | Nov 03, 2021 | Sale | $8.34 | 378 | 3,152 | 7,533 | Nov 04, 2021, 08:00 AM |
| Trask Anna | SEE REMARKS | Nov 02, 2021 | Sale | $8.31 | 4,913 | 40,827 | 7,911 | Nov 03, 2021, 04:16 PM |
| Trask Anna | See Remarks | Oct 14, 2021 | Sale | $7.55 | 5,364 | 40,481 | 12,824 | Oct 15, 2021, 04:57 PM |
| Reid Laurence | President and Chief Executive | Sep 15, 2021 | Buy | $7.64 | 10,000 | 76,400 | 25,849 | Sep 17, 2021, 09:48 PM |
| ORBIMED ADVISORS LLC | Director | Feb 17, 2021 | Buy | $18.00 | 1,666,666 | 29,999,988 | 3,843,206 | Feb 19, 2021, 07:09 PM |
| Foy Matthew | Director | Feb 17, 2021 | Buy | $18.00 | 150,000 | 2,700,000 | 1,183,663 | Feb 19, 2021, 06:59 PM |
| Casdin Partners Master Fund, L.P. | 10% Owner | Feb 17, 2021 | Buy | $18.00 | 575,000 | 10,350,000 | 1,121,421 | Feb 19, 2021, 06:56 PM |
| Thompson Peter A. | Director | Feb 17, 2021 | Buy | $18.00 | 1,666,666 | 29,999,988 | 3,843,206 | Feb 19, 2021, 06:50 PM |
| GLAXOSMITHKLINE PLC | Director | Feb 17, 2021 | Buy | $18.00 | 150,000 | 2,700,000 | 1,183,663 | Feb 19, 2021, 04:50 PM |
Load More Insider Transactions
Buy
Sale
Option Exercise
| Owner | Relationship | Date | Value($) |
| Trask Anna | See Remarks | 12/02/2021 | 33,688 |
| Trask Anna | See Remarks | 11/03/2021 | 3,152 |
| Trask Anna | SEE REMARKS | 11/02/2021 | 40,827 |
| Trask Anna | See Remarks | 10/14/2021 | 40,481 |
| Reid Laurence | President and Chief Executive | 09/15/2021 | 76,400 |
| ORBIMED ADVISORS LLC | Director | 02/17/2021 | 29,999,988 |
| Foy Matthew | Director | 02/17/2021 | 2,700,000 |
| Casdin Partners Master Fund, L.P. | 10% Owner | 02/17/2021 | 10,350,000 |
| Thompson Peter A. | Director | 02/17/2021 | 29,999,988 |
| GLAXOSMITHKLINE PLC | Director | 02/17/2021 | 2,700,000 |
Load More Insider Transactions
CHANGE IN SHARES OUTSTANDING FOR DECIBEL THERAPEUTICS INC
STOCK BUYBACKS FOR DECIBEL THERAPEUTICS INC
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
Load More
Period of Report: 06/30/2023
10-K/10-Q Filings: View
Previous Period
% Change in Shares
Quarter
03/31/2023
0.11%
1Q
12/31/2022
0.21%
2Q
09/30/2022
0.22%
3Q
06/30/2022
0.24%
4Q
03/31/2022
0.25%
5Q
12/31/2021
0.27%
6Q
09/30/2021
0.58%
7Q
06/30/2021
0.61%
8Q
Load More
BUYBACK ANNOUNCEMENT(S) FOR DECIBEL THERAPEUTICS INC
LOADING...